New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:07 EDTAMPEAmpio' subisidary establishes study collaboratoins with two research centers
Ampio announced that subsidiary Luoxis has entered into research agreements with Western Galilee Medical Center and the University of Thessaly. These two leading oxidative stress research groups will utilize Luoxis' proprietary RedoxSYS oxidation-reduction potential diagnostic system to study oxidative stress markers across hypertension, hemodialysis, sepsis, and physical exertion.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
07:42 EDTAMPEAmpio confirms sales agreement with Cantor Fitzgerald
Ampio Pharmaceuticals entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald. CEO Michael Macaluso stated "During our most recent conference call, we stated that we are not currently raising money and that we have enough money to get us through 2016 and into 2017 and still complete all of our current objectives and nothing has changed since that conference call. The "at-the-market" program may be used opportunistically and as a contingency facility to strengthen our position post-Ampion trial data."
07:36 EDTAMPEAmpio enters $20M controlled equity offering sales agreement with Cantor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use